Skip to main content
See details

Reimbursement summary for angioplasty of arteries of lower extremities

This post presents an extract from our reimbursement analysis for angioplasty of arteries lower extremities using plain and drug-coated balloons (DCBs) for peripheral artery disease in England, France and Germany. Plain balloon angioplasty is reimbursement via DRG solely and DCBs are reimbursement via combination of DRG and add-on reimbursement.
See details

Assessment of surgical procedures for obesity treatment released in Norway

On March 18, 2022, the Norwegian National Institute of Public Health (NIPH) released a health technology assessment report on the evaluation of surgical procedures for the treatment of obesity. The current assessment compares the effectiveness of different surgical procedures for the treatment of obesity among adults. The authors came to the following key conclusions:

  • It is uncertain whether there is any difference in the risk of early mortality between different types of surgical procedures for the treatment of obesity;
  • It is uncertain whether there is any difference in effect on weight status between different surgical procedures for the treatment of obesity;
  • There may be little or no difference in the effect on diabetes status between different surgical procedures for the treatment of obesity;
  • There may be little or no difference in the effect on HRQOL between different types of surgery for the treatment of obesity.

It was specifically outlined that the differences in costs between the surgical procedures most commonly used in Norway are negligible, and since the current evidence suggests that the choice of the procedure has a limited impact on the outcomes with the greatest impact on cost-effectiveness, the comprehensive health economic analysis was not conducted.

The full details in Norwegian can be found here.

This news is just one of about 300 market access news collected by our team in the subscription services “HTA Alerts” and “Reimbursement Alerts” every two weeks from more than 80 organizations. Access our paid subscription services to stay on top of all developments specifically for your products in Europe (reimbursement news) and globally (HTA news).

Not ready for a subscription service? Subscribe to our free-of-charge newsletter delivered every second week to get updates about key reimbursement developments in Europe (10-12 news every two weeks). First EU issues of both newsletters are available for download free-of-charge.